EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Inhibition of MCCC2 Impedes TNBC Progression by Downregulating Leucine Metabolism-Dependent mTOR Signaling

Rui Chi, Jin Zhang, Zheng Li, Yi Xie, Quanquan Zheng, Jiayi Chen, Yunxia Liu, Fang Gong

Breast Cancer: Targets and Therapy · 2026-03 · Volume 18 · 1-14

DOI: 10.2147/bctt.s579112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-03. Verfasst von Rui Chi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Jiangnan University Medical Center (Wuxi No.2 People's Hospital), Jiangnan University, Wuxi, Jiangsu, 214122, Peop…. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

MCCC2TNBCleucine metabolismmTOR

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Jiangnan University Medical Center (Wuxi No.2 People's Hospital), Jiangnan University, Wuxi, Jiangsu, 214122, People's Republic of China.
  • Department of General Surgery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, People's Republic of China.
  • The Affiliated Suzhou Hospital of Nanjing University Medical School, Suzhou, Jiangsu, 215153, People's Republic of China.
  • Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, People's Republic of China.
  • School of Life Sciences, Jilin University, Changchun, Jilin, 130012, People's Republic of China.
  • National University of Singapore Duke-NUS Medical School, Singapore, 169857, Singapore.

Zitieren

APA

Chi, R., Zhang, J., Li, Z., Xie, Y., Zheng, Q., Chen, J., Liu, Y., & Gong, F. (2026). Inhibition of MCCC2 Impedes TNBC Progression by Downregulating Leucine Metabolism-Dependent mTOR Signaling. Breast Cancer: Targets and Therapy, Volume 18, 1-14. https://doi.org/10.2147/bctt.s579112

Vancouver

Chi R, Zhang J, Li Z, Xie Y, Zheng Q, Chen J, et al. Inhibition of MCCC2 Impedes TNBC Progression by Downregulating Leucine Metabolism-Dependent mTOR Signaling. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-14. doi:10.2147/bctt.s579112

BibTeX
@article{Chi2026,
  author = {Chi, Rui and Zhang, Jin and Li, Zheng and Xie, Yi and Zheng, Quanquan and Chen, Jiayi and Liu, Yunxia and Gong, Fang},
  title = {Inhibition of MCCC2 Impedes TNBC Progression by Downregulating Leucine Metabolism-Dependent mTOR Signaling},
  journal = {Breast Cancer: Targets and Therapy},
  year = {2026},
  volume = {Volume 18},
  pages = {1--14},
  doi = {10.2147/bctt.s579112}
}
Kostenlos starten →